By Dietrich Knauth (Reuters) – Johnson & Johnson said on Monday it agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid addiction crisis in the state, removing the company from an ongoing trial that began earlier this month. West Virginia is still pursuing claims against Teva Pharmaceuticals Industries Ltd and AbbVie Inc’s Allergan in the Kanawha County Circuit Court trial for their alleged role in the crisis. The state accused the companies of causing a “tsunami” of addiction. J&J did not admit liability or wrongdoing in the settlement, the company said. T…